Skip to main content

An update on the STRAVINSKY study: understanding who is most clinically vulnerable to COVID-19

BSI supported event
Register here

The ‘Stratification of Clinically Vulnerable People for COVID-19 Risk Using Antibody Testing’ (STRAVINSKY) study is pleased to hold a free public webinar on Wednesday 24 April 18:00-19:00 to provide an update on the project’s progress so far as well as the current situation around COVID-19 for people with weakened immune systems. 

STRAVINSKY is a 2-year study, which aims to build our understanding of who is most clinically vulnerable to COVID-19 infection and identify individuals or disease groups at highest risk. Using this information, STRAVINSKY hopes to assess the effectiveness of COVID-19 booster vaccine programmes or new treatment strategies for these patients. 

Come along to this free webinar to join the study research team and hear more about STRAVINSKY’s progress so far and what the study has found, and to ask any questions. STRAVINSKY is continuing to recruit patients to take part in the research, so if you’re still considering whether to get involved, come along to find out what’s involved.

This webinar is for a public audience with the opportunity for everyone to ask questions to our speaker. Questions can be submitted beforehand via the registration link below or you can ask them live at the event. All questions submitted will be treated in an anonymous manner. Please note, we’re unable to answer questions about individual medical needs. 

Registration is free for all for this webinar. Book your place here


  • Professor Alex Richter, STRAVINSKY lead researcher, University of Birmingham 


  • Hana Ayoob, British Society for Immunology